McClellan Resigns As Head Of CMS, Claiming Drug Benefit Is On A Stable Track
This article was originally published in The Pink Sheet Daily
Executive Summary
McClellan notes accomplishments in implementing Medicare Part D as he ends two-and-a-half years as Medicare and Medicaid chief.
You may also be interested in...
Randall Lutter Appointed FDA Acting Deputy For Policy
Lutter will step in when Scott Gottlieb leaves the post Jan. 16.
Randall Lutter Appointed FDA Acting Deputy For Policy
Lutter will step in when Scott Gottlieb leaves the post Jan. 16.
Deputy Commissioner Scott Gottlieb To Leave FDA Jan. 16
Gottlieb will return to the American Enterprise Institute to work on health policy issues with former FDA/CMS chief Mark McClellan.